LFVN Lifevantage

LifeVantage to Participate at the LD Micro Main Event XVII

LifeVantage to Participate at the LD Micro Main Event XVII

SALT LAKE CITY, Oct. 24, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the LD Micro Main Event XVII, to be held October 28-30, 2024 in Los Angeles, CA.

Mr. Fife and Mr. Aure will meet with investors and present at approximately 4:30 p.m. Eastern Time on Wednesday, October 30, 2024. A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at  or directly .

About LifeVantage Corporation

LifeVantage Corporation® (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System™, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own sales business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit .

Investor Relations Contact:

Reed Anderson, ICR

(646) 277-1260



EN
24/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE

LifeVantage to Participate at the Sidoti Micro Cap Conference

LifeVantage to Participate at the Sidoti Micro Cap Conference SALT LAKE CITY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Sidoti Micro Cap Conference, to be held November 13-14, 2024. Mr. Fife and Mr. Aure will meet virtually with investors and present at approximately 1:00 p.m. Eastern Time on Wednesday, No...

 PRESS RELEASE

LifeVantage Announces Financial Results for the First Quarter of Fisca...

LifeVantage Announces Financial Results for the First Quarter of Fiscal 2025 SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2024. First Quarter Fiscal 2025 Summary*: Revenue of $47.2 million, a decrease of 8.1% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was down approximately...

 PRESS RELEASE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid December 16, 2024 to all stockholders of record at the close of business on December 2, 2024. About LifeVantage Corporation LifeVantage Corporation® (Nasdaq: LFVN), the Activation company, is a p...

 PRESS RELEASE

LifeVantage Reports Full Clinical Results Including Average of 140% In...

LifeVantage Reports Full Clinical Results Including Average of 140% Increase in GLP-1 with the MindBody GLP-1 System™Ω Natural Approach to GLP-1 Activation Proves Effective Without Common Side Effects* SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leader in health and wellness solutions designed to activate optimal health processes at the cellular level, today announced groundbreaking results from a human clinical trial performed on the new MindBody GLP-1 System™. Results from the trial included a 140% average increase in GLP-1 levels in the...

 PRESS RELEASE

LifeVantage to Participate at the LD Micro Main Event XVII

LifeVantage to Participate at the LD Micro Main Event XVII SALT LAKE CITY, Oct. 24, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the LD Micro Main Event XVII, to be held October 28-30, 2024 in Los Angeles, CA. Mr. Fife and Mr. Aure will meet with investors and present at approximately 4:30 p.m. Eastern Time on Wednesday, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch